These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans. Londong W Aliment Pharmacol Ther; 1994; 8 Suppl 1():39-46. PubMed ID: 8180293 [TBL] [Abstract][Full Text] [Related]
23. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole. Andersson T; Holmberg J; Röhss K; Walan A Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184 [TBL] [Abstract][Full Text] [Related]
25. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction. Masubuchi N; Hakusui H; Okazaki O Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973 [TBL] [Abstract][Full Text] [Related]
26. Pantoprazole, Prout and the proton pump. Playford RJ; Podas T; Modlin I Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542 [TBL] [Abstract][Full Text] [Related]
27. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole. Schepp W; Rehner M; Witzel L Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295 [TBL] [Abstract][Full Text] [Related]
28. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936 [TBL] [Abstract][Full Text] [Related]
29. Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole. Härtter S; Connemann B; Schönfeldt-Lecuona C; Sachse J; Hiemke C J Clin Psychopharmacol; 2004 Oct; 24(5):568-71. PubMed ID: 15349025 [No Abstract] [Full Text] [Related]
30. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Fitton A; Wiseman L Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382 [TBL] [Abstract][Full Text] [Related]
31. Lichenoid drug eruption with proton pump inhibitors. Bong JL; Lucke TW; Douglas WS BMJ; 2000 Jan; 320(7230):283. PubMed ID: 10650025 [No Abstract] [Full Text] [Related]
33. [Do other proton pump blockers have advantages over Antra (omeprazole)?]. Creutzfeldt W Internist (Berl); 1996 Sep; 37(9):936-7. PubMed ID: 8964689 [No Abstract] [Full Text] [Related]
34. Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors. Masubuchi N; Hakusui H; Okazaki O Drug Metab Dispos; 1997 May; 25(5):584-9. PubMed ID: 9152597 [TBL] [Abstract][Full Text] [Related]
39. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole. Levine A; Shevah O; Shabat-Sehayek V; Aeed H; Boaz M; Moss SF; Niv Y; Avni Y; Shirin H Aliment Pharmacol Ther; 2004 Jul; 20(1):117-22. PubMed ID: 15225178 [TBL] [Abstract][Full Text] [Related]
40. Safety profile of the proton-pump inhibitors. Reilly JP Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S11-7. PubMed ID: 10597119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]